Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure: a case report and in vitro analysis of isolates from prosthetic joint infections.

"data availability the datasets generated and analysed during the current study are available from the european nucleotide archive (ena) under bioproject accession number prjeb55821. data availability the datasets generated and analysed during the current study are available from the european nucleotide archive (ena) under bioproject accession number prjeb55821"

"Transparency declarations: B.S. is a member of an advisory board at ADVANZ PHARMA. B.S. also gave a lecture about prosthetic joint infections at Correvio Pharma Corp. in 2019, receiving financial compensation. The other authors declare no conflicts of interest.: Author contributionsB.S., S.T. and M.S. contributed to the design of the work. S.T. collected the medical data. J.A.J. and B.S. performed the microbiological analysis. M.S. and R.N.S. performed the genome sequencing and the bioinformatic analyses. S.T. and J.A.J. wrote the manuscript draft, and M.S., R.N.S. and B.S. made critical revisions. All authors have read and approved the final manuscript."

"Funding This work was supported by the research committee of Region Värmland (grant numbers LIVFOU-968115, LIVFOU-939253, LIVFOU-939836); ALF funding for Region Örebro County; and Nyckelfonden at Örebro University Hospital (grant number OLL-935525)."